Related Experiment Video
Updated: Jun 18, 2025

07:30
Using Chronic Social Stress to Model Postpartum Depression in Lactating Rodents
Published on: June 10, 2013
24.8K
The intersection between menopause and depression: overview of research using animal models
José Jaime Herrera-Pérez1, Olivia Tania Hernández-Hernández2, Mónica Flores-Ramos3
1Laboratorio de Farmacología Conductual, Dirección de Investigaciones en Neurociencias, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico City, Mexico.
Frontiers in Psychiatry
|July 31, 2024
Summary
Menopausal depression is complex, but estrogen replacement therapy (ERT) shows promise. Animal models reveal ERT
Area of Science:
- Neuroscience and Endocrinology
- Reproductive Biology
- Psychiatry
Background:
- Menopausal transition can trigger depression due to fluctuating estrogen levels.
- Estrogen replacement therapy (ERT) effectiveness for menopausal depression is debated.
- Menopausal depression has a complex, multifactorial origin, complicating treatment.
Purpose of the Study:
- To review and compare animal models of menopause and their utility in studying depression.
- To evaluate the efficacy and mechanisms of conventional and novel ERTs for menopausal depression.
- To discuss factors influencing antidepressant responses to ERT in menopausal models.
Main Methods:
- Review of preclinical studies using ovariectomized rats, aged intact rats, and reprotoxic-treated females as menopausal models.
- Analysis of various menopausal stages, from surgical menopause to perimenopause.
- Discussion of organistic and therapeutic variables affecting ERT efficacy.
Main Results:
- Animal models demonstrate dynamic brain changes during menopausal transition and depression onset.
- Findings highlight the importance of timely intervention and tailored treatment based on reproductive tissue presence.
- New promising estrogens with potential antidepressant properties have been identified.
Conclusions:
- Animal models are crucial for understanding menopausal depression and ERT efficacy.
- Optimal treatment requires considering the menopausal stage and individual patient factors.
- Novel ERTs may offer effective alternatives for menopausal depression when traditional therapies fail.
Keywords:
accelerated ovarian failureagingestropausemiddle ageovarian hormonesovariectomyperimenopausepost-ovariectomy time frameMore Related Videos
Related Concept Videos
Menopause
147
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
147
Depression: Overview
230
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
230

